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Background: Neonatal sepsis (NS) is one of the leading causes of infant morbidity and
mortality, but little is known about pathogen incidence and distribution in China.
Methods: In this retrospective study (January 2012 to December 2016), culture-proven cases
aged less than 28 days with diagnosed NS in the Guangzhou Women and Children’s Medical
Center, South China, were analyzed for pathogen incidence and antimicrobial resistance.
Results: A total of 620 isolates were identified from 597 NS cases. Gram-negative bacteria
(n=371, 59.8%) dominated over Gram-positive bacteria (n=218, 35.2%) and fungi (n=30, 4.8%).
Klebsiella pneumoniae (21.9%), Escherichia coli (21.9%), group B Streptococcus (GBS,
13.2%), and Staphylococcus aureus (6.8%) were the four most predominant pathogens. In early-
onset sepsis (EOS), GBS (30.0%) and E. coli (20.0%) were dominant, whereas in late-onset
sepsis (LOS), K. pneumoniae (25.6%) and E. coli (22.4%) were dominant. E. coli (25.2%) and
GBS (17.7%) were the most frequently isolated from term patients, whereas K. pneumoniae was
the most frequently isolated from preterm patients (34.9%). Of the infected infants, 9.5% died
from sepsis, most commonly by E. coli infection (16.2%). Among 91,215 live births (LBs)
delivered in the study hospital (2012–2016), 252 infants developed sepsis infection (2.76 per
1000 LBs, 95% CI 2.4–3.1), including EOS (0.78 per 1000 LBs) and LOS (2.13 per 1000 LBs).
All GBS isolates were susceptible to β-lactam antibiotics, and S. aureus, including methicillin-
resistant isolates, were susceptible to vancomycin. An extended-spectrum β-lactamase producer
was identified in 37.3% of E. coli and 50.4% of K. pneumoniae.
Conclusion: K. pneumoniae was the most frequent pathogen in culture-proven NS in South
China, primarily associated with LOS in preterm, whereas GBS was the dominant pathogen
in EOS. E. coli was common in both episodes with the highest mortality.
Keywords: neonatal sepsis, incidence, antimicrobial resistance, Escherichia coli, group
B Streptococcus, Klebsiella pneumoniae
Introduction
Neonatal sepsis (NS) is one of the leading causes of morbidity and mortality in infants
worldwide.1 It is classically divided into early-onset sepsis (within the first 72 h of life,
EOS) and late-onset sepsis (3–28 days after birth, LOS), depending on the age at the
onset of the sepsis episode. Neonatal sepsis can result from infections by bacteria,
viruses, or fungi. Early-onset sepsis is usually the result of vertical maternal transmis-
sion before or during delivery, whereas LOS is acquired from interaction with the
environment of the communities.1 A general method to diagnose pathogens of this
systemic condition is to examine the culture of blood or sterile body fluids such as
cerebrospinal fluid (CSF). The incidence and distribution of pathogens, as well as their
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responses to antimicrobial agents, may vary temporally and
geographically, which can affect the decisions for local pre-
ventive policy and clinical management.
Group B Streptococcus (GBS) and Escherichia coli are
considered historically as the dominant pathogens of EOS.1
By comparison, in LOS, GBS,E. coli or other Gram-negative
aerobes, or Listeria monocytogenes may cause infection.2
Invasive GBS infections in Chinese infants have been sup-
posed to be very rare because of the lower rate of GBS
colonization in pregnant women and the higher protective
antibody concentrations in mothers, so that preventive mea-
surements have been suspended.3 However, the results of
a study in China are not consistent with these
observations,4 and in recent years, the trend of neonatal
GBS cases from mainland China is increasing. Moreover,
in a previous multicenter study of infants aged less than
3 months, the overall incidence of invasive GBS infection
of 0.55/1000 live births was higher than the global mean.5 In
particular, the incidence of early-onset GBS disease
increased significantly from 2011 to 2014. With the increase,
the incidence is almost two times that in the USA where
universal culture-based screening of pregnant women and
intrapartum antibiotic prophylaxis for GBS-colonized
women have been widely employed.6 Nevertheless, the dis-
ease burden caused by GBS infection remains unclear when
compared with other pathogens in NS. It is also unclear
whether preventive measures are required in China because
studies are limited, the data from certain departments in
hospitals such as neonatal intensive care units (NICU) are
insufficient, some studies extend the neonates to 1 year of
age, and compared with international definitions, EOS and
LOS groups are vaguely defined.7–9
In this retrospective study, culture-proven cases diag-
nosed with NS in a South China hospital were analyzed
for microorganism profiles and the antimicrobial resis-
tance of bacterial pathogens from 1 January 2012 to
31 December 2016. The study included many cases, and
therefore, sufficient evidence may be provided to imple-
ment preventive measures and empirical antimicrobial
treatment for neonates suffering from sepsis in the future.
Materials And Methods
Study Design And Population
Culture-positive results of blood or CSF from neonates
aged less than 28 days were extracted from the microbiol-
ogy laboratory database at the Guangzhou Women and
Children’s Medical Center (GWCMC), Guangzhou,
Guangdong Province, China. The microbiological and
clinical data of neonates with culture-proven sepsis were
reviewed from 1 January 2012 to 31 December 2016, and
information was collected on antimicrobial resistance of
isolated organisms, gestational age, birth weight, and out-
comes when discharged from the hospital. Whether the
infants were born in the study hospital or were born out-
side the study hospital but transferred to the hospital was
also recorded.
The study protocol was reviewed and approved by the
ethical committees of the GWCMC, and the study was
conducted in accordance with the principles of Good
Pharmacoepidemiological Practice and the Declaration of
Helsinki. The records of patients remained anonymous
during data collection and analysis. Written parental con-
sent was not required.
The GWCMC is the largest medical center in South
China and has three tertiary hospitals that provide labor
service and neonatal and pediatric health care. The
GWCMC has 15,000–22,000 annual deliveries and has
300 beds for neonatal hospitalization, of which 120 are
designated for intensive care.
Culture And Identification
Microorganism identification and culture were conducted
according to the routine diagnostic standard operation
procedure used by the clinical laboratory in the study
hospital: for any infant presenting with clinical signs or
symptoms of sepsis, meningitis, or pneumonia, 1–3 mL of
blood or 0.5–3 mL of CSF sample was inoculated into
a commercial culture bottle exclusively for newborns and
analyzed using an automated monitoring system for bac-
terial detection (BD BACTEC™; Franklin Lake, NJ, USA
or BioMérieux Bact/ALERT, Marcy L’Étoile, France).
Incubation was continued until a positive result was
observed or up to a maximum of 7 days. The microorgan-
isms were identified to species level by conventional bio-
chemical techniques or automated methods with the
VITEK system (BioMérieux). The bacterial isolates were
tested for susceptibility to antibiotics using VITEK 2
Compact (BioMérieux) or the manual Kirby–Bauer disc
diffusion method, as per interpretive standards established
by the Clinical Laboratory Standards Institute (USA).
Definitions
Culture-proven NS was defined as one or more blood or CSF
culture obtained at 0–28 days of life growing a recognized
pathogenic bacterium or fungus and a clinical diagnosis of
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sepsis.10,11 Coagulase-negative staphylococci (CoNS),
micrococci, propionibacteria, corynebacteria, or diphtheroids
grown alone in a single sample were considered contami-
nants and excluded. CoNS were included only when culti-
vated in two or more blood/CSF samples. Repeatedly
positive samples were considered to represent the same epi-
sode of infection, unless they occurred more than 21 days
after the last positive culture result. The date of sepsis onset
was the date of collection of the first blood sample yielding
a pathogenic strain. Early-onset sepsis was defined as infec-
tion occurring less than 72 h after birth, whereas episodes
thereafter (3–28 days after birth) were classified as LOS.
Preterm was defined as <37 weeks of gestation. The
preterms were categorized by birth weight: very low birth
weight (VLBW), <1500 g; low birth weight (PLBW),
1500–2499 g; normal, 2500–3999 g; overweight, ≥4000 g.
Only neonates born in the study hospital were included
in the incidence estimation to ensure a constant denomi-
nator, and those cases born outside the study hospital were
excluded from the calculation. The statistical department
of the study hospital provided the total numbers of live
births per year from 2012 to 2016. The incidence rates
were calculated as cases per 1000 live births (LBs), and
the 95% confidence intervals (CIs) for the incidence rates
were based on the assumption that the annual case count
followed a Poisson distribution.
Statistical Analyses
SPSS 20.0 (IBM, Armonk, NY, USA) was used for data
analyses. Discrete data are presented as frequencies, which
were compared with a χ2 test or Fisher exact test. P<0.05
was considered significant. The case fatality rate of
a certain organism was defined as the percentage (%) of
the cases with diagnosed sepsis caused by the organism in
which the neonates died before discharge. The incidence
per 1000 LBs of a certain organism was calculated as the
total number of cases diagnosed with the organism-caused
sepsis born in the study hospital divided by the total
number of infants in the study hospital birth cohort, multi-
plied by 1000.
Results
Characteristics Of Infants
Between 1 January 2012 and 31 December 2016, 597
infants with positive cultures of samples obtained at ≤28
days of age and diagnosed with NS were identified, includ-
ing 382 boys (64.0%) and 215 girls (36.0%). The median
age was 10 days. Of these infants, seven neonates (1.2%)
experienced more than one episode of infection caused by
different pathogens. Multiple organisms were isolated
from the same culture in 2.0% (n=12) of episodes.
According to the time of onset, 97 cases were classified
as EOS and 502 cases as LOS. Two neonates developed
NS in EOS and LOS with different pathogens. All of the
patients were collected from the general neonatal unit,
NICU, cardiac ICU, surgical ICU, or emergency depart-
ment set in the study hospital. Of the infants, 388 (65.0%)
were born at term, 206 (34.5%) were preterm, and 3
(0.5%) had no gestational age records because they were
foundlings without any information at birth. Of the 206
preterms, 71 (11.9%) were categorized as PLBW and 54
(9.0%) as VLBW.
Fifty-seven (9.5%) patients died from sepsis before
being discharged from the hospital. Escherichia coli infec-
tion was the leading cause of mortality at 16.2% (22/136),
followed by Klebsiella pneumoniae at 8.8% (12/136),
GBS at 4.9% (4/82), and Staphylococcus aureus at 4.8%
(2/42). The death rate between neonates with EOS (9.0%)
and LOS (9.2%) was not different (P>0.05).
Organisms Causing Neonatal Sepsis
A total of 620 isolates were identified (Table 1). Sepsis was
primarily caused by Gram-negative bacteria (n=371, 59.8%),
compared with Gram-positive bacteria (n=218, 35.2%) and
fungi (n=31, 5.0%). The most frequent pathogens were
K. pneumoniae (n=136, 21.9%) and E. coli (n=136,
21.9%), followed by GBS (n=82, 13.2%) and S. aureus
(n=42, 6.8%). Other pathogens included Enterococcus spe-
cies at 4.9%, CoNS at 4.0%, Acinetobacter baumannii at
1.1%, Pseudomonas aeruginosa at 0.6%, and L. monocyto-
genes at 0.3%. Fungal pathogens were at 5.0%, and Candida
was the most prevalent. The profiles of the microorganisms
isolated from the terms and preterms are shown in Figure 1.
The most common bacteria isolated from the terms were
E. coli (n=98, 25.2%), GBS (n=69, 17.7%), K. pneumoniae
(n=58, 15.0%), and S. aureus (n=29, 7.5%). Of the infections
in terms, GBS caused 86.6% (71/82), E. coli 74.2% (101/
136), and S. aureus 69.0% (29/42). Compared with term
neonates, K. pneumoniae (34.9%) rather than E. coli
(15.8%) was the most common bacteria in preterm NS neo-
nates (P<0.001), including in both VLBW (35.1% vs 15.8%,
P<0.001) and PLBW (32.0% vs 13.3%, P<0.001) neonates.
GBSwas also less commonly isolated in preterm (5.1%) than
in term (17.7%) neonates (P=0.000). Fungi were more
Dovepress Gao et al
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commonly isolated in preterm (7.9%) than in term (3.2%)
neonates (P=0.03).
Pathogens In EOS And LOS
In EOS patients, Gram-positive bacteria (n=54, 54.0%)
were the main pathogens (Table 1). The most frequent
pathogen was GBS (n=30, 30.0%), followed by E. coli
(n=20, 20.0%). The prevalence of GBS was always greater
than that of E. coli in each year of study, but the trends in
variation were synchronous for these two bacteria from
2012 to 2016 (Figure 2A). Serratia marcescens (n=5,
5.0%), Ochrobactrum anthropi (n=5, 5.0%), and CoNS
(n=5, 5.0%) were also recorded.
In LOS patients, Gram-negative bacteria were the main
pathogens (n=327, 63.0%). The prominent pathogens dur-
ing the study period were K. pneumoniae (n=133, 25.6%)
and E. coli (n=116, 22.3%) (Figure 2B), followed by GBS
(n=52, 10.0%) and S. aureus (n=40, 7.7%).
Incidence
Of the 597 NS neonates, 252 (42.0%) were born in the
GWCMC: 69 with EOS and 185 with LOS, including four
neonates who experienced both EOS and LOS, and some
had multiple organisms isolated from the same culture. Of
the 265 isolates from the in-born patients, K. pneumoniae
(n=72, 27.2%), E. coli (n=43, 16.2%), GBS (n=42,
15.8%), and S. aureus (n=19, 7.2%) remained the main
pathogens, with GBS (27/71, 38.0%) dominating in EOS
and K. pneumoniae (71/194, 36.6%) dominating in LOS.
In EOS, K. pneumoniae (1/71) and S. aureus (2/71) infec-
tions seldom occurred, whereas the infection rate by
E. coli was similar in EOS (10/71) and LOS (33/194,
χ2=0.327, P>0.05).
During the study period, a total of 91,215 LBs were
delivered in the GWCMC. The overall incidence rate of NS
was 2.76 per 1000 LBs (252/91,215; 95% CI 2.4–3.1). The
incidence of EOS was 0.78 per 1000 LBs (71/91,215; 95%
CI 0.61–0.97) and that of LOS was 2.13 per 1000 LBs (185/
91,215; 95% CI 1.75–2.33). The average incidence of infec-
tion in NS for the four predominant pathogens was as
follows: K. pneumoniae, 0.79 per 1000 LBs (72/91,215;
95% CI 0.62–0.98); E. coli, 0.47 per 1000 LBs (43/
91,215; 95% CI 0.34–0.62); GBS, 0.46 per 1000 LBs (42/
91,215; 95% CI 0.33–0.61); and S. aureus, 0.21 per 1000
LBs (19/91,215; 95% CI 0.13–0.31). In EOS, GBS had the
highest incidence (0.30 per 1000 LBs; 95% CI 0.20–0.42)
among the four major bacteria over the five study years,
followed by E. coli (0.11 per 1000 LBs; 95% CI 0.05–0.19;
Figure 3). In LOS, K. pneumoniae (0.78 per 1000 LBs; 95%
CI 0.61–0.97) and E. coli (0.36 per 1000 LBs; 95% CI
0.25–0.50) were the major bacteria. Streptococcus aureus
(0.19 per 1000 LBs; 95% CI 0.11–0.29) and GBS (0.16 per
1000 LBs; 95% CI 0.09–0.26) were also common in LOS.
Antimicrobial Resistance
Antibiotic susceptibility of Gram-positive GBS and S. aureus
was selected as shown in Table 2. All GBS isolates tested
were sensitive to penicillin, ampicillin, and vancomycin;
Table 1 Distribution Of Organisms Causing Neonatal Sepsis
Organism Total
(n/%)
Early
Onset
Sepsis
(n/%)
Late
Onset
Sepsis
(n/%)
Gram-negative bacteria 371/59.8 44/44.0 327/63.0
Klebsiella pneumonia 136/21.9 3/3.0 133/25.6
Escherichia coli 136/21.9 20/20.0 116/22.3
Serratia marcescens 16/2.6 5/5.0 11/2.1
Enterobacter cloacae 12/1.9 1/1.0 11/2.1
Ochrobactrum anthropi 12/1.9 5/5.0 7/1.3
Acinetobacter baumannii 7/1.1 1/1.0 6/1.2
Stenotrophomonas
maltophilia
6/1.0 5/5.0 1/0.2
Enterobacter aerogenes 6/1.0 0/0.0 6/1.2
Alcaligenes xylosoxidans 5/0.8 1/1.0 4/0.8
Chryseobacterium
meningosepticum
5/0.8 0/0.0 5/1.0
Other Gram-negative
bacteria
30/4.8 8/8.0 27/5.2
Gram-positive bacteria 218/35.2 54/54.0 164/31.5
Group B Streptococcus 82/13.2 30/30.0 52/10.0
Staphylococcus aureus 42/6.8 2/2.0 40/7.7
Coagulase-negative
Staphylococcus
25/4.0 5/5.0 20/3.8
Enterococcus faecalis 19/3.1 2/2.0 17/3.3
Enterococcus faecium 11/1.8 1/1.0 10/1.9
Streptococcus mitis 8/1.3 3/3.0 5/1.0
Streptococcus pasteurianus 3/0.5 2/2.0 1/0.2
Streptococcus gallolyticus 3/0.5 1/1.0 2/0.4
Streptococcus milleri 3/0.5 3/3.0 0/0.0
Other Gram-positive
bacteria
22/3.6 5/5.0 17/3.3
Fungi 31/5.0 2/2.0 29/5.6
Candida albicans 13/2.1 0/0.0 13/2.5
Candida parapsilosis 8/1.3 1/1.0 7/1.3
Candida guilliermondii 3/0.5 0/0.0 3/0.6
Other fungi 7/1.1 1/1.0 6/1.2
Total 620/100 100/100.0 520/100.0
Gao et al Dovepress
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however, many were highly resistant to erythromycin
(70.9%), clindamycin (64.0%), and tetracycline (88.4%).
Of the 42 S. aureus isolates, nine (21.4%) were considered
methicillin-resistant S. aureus (MRSA). β-Lactamase was
produced in 80.8% of S. aureus (26 tested).
In the tested isolates, 37.3% of E. coli and 50.4% of
K. pneumoniae produced extended-spectrum β-lactamase.
The resistance of E. coli to ampicillin was 79.1%, to
ceftriaxone 41.8%, and to imipenem 0.7%. The resistance
of K. pneumoniae to ampicillin, ceftriaxone, and imipenem
was 6.3%. Both E. coli and K. pneumoniae exhibited high
resistance to third-generation cephalosporin (ceftriaxone)
and ampicillin but relatively low resistance to amikacin
and imipenem (Table 3).
Discussion
For clinicians to consider optimal prevention and treatment
strategies, it is important to monitor and understand the
distribution of bacterial pathogens causing NS, as well as
their antimicrobial resistance for following clinical manage-
ment. The bacterial spectrum may vary geographically and
temporally, and this variability can be affected by antibiotic
use and implementation of preventive measures.1 In addi-
tion, the attitude adopted toward CoNS can contribute to the
0.0%
10.0%
20.0%
30.0%
40.0%
2012 2013 2014 2015 2016
A: Early-onset sepsis
E.coli GBS K.pneumoniae S. aureus
0.0%
10.0%
20.0%
30.0%
40.0%
2012 2013 2014 2015 2016
B: Late-onset sepsis
E.coli GBS K.pneumoniae S. aureus
Figure 2 Annual trends of the four predominant pathogens (Klebsiella pneumoniae, Escherichia coli, Group B Streptococcus (GBS), and Staphylococcus aureus) in (A) early-onset
sepsis (EOS) and (B) late-onset sepsis (LOS) during 2012–2016.
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
Term Preterm PLBW VLBW
Other Gram-positive bacteria Other  Gram-negative bacteria Fungi CoNS S. aureus GBS K.pneumoniae E.coli
Figure 1 Proportions of term and preterm neonates, including very low birth weight (VLBW) and preterm low birth weight (PLBW), infected by different bacteria. CoNS,
Coagulase-negative Staphylococcus; S. aureus, Staphylococcus aureus; GBS, Group B Streptococcus; K. pneumoniae, Klebsiella pneumoniae; E. coli, Escherichiacoli.
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differences in bacterial spectra that are pervasive in various
studies. When CoNS are counted, Gram-positive bacteria
are reported as the main cause of NS in most countries,
which is similar to most other hospitals in China, reporting
the highest percentage of 84%.11–13 Of the Gram-positive
bacteria, CoNS account for a large proportion. When CoNS
are not counted or only the positive results in the second
culture are counted, as in the present study, Gram-negative
bacteria are the prominent pathogens.10,14,15 In these studies
eliminating the uncertainty caused by CoNS, E. coli and
S. aureus are always reported as the most common bacteria
in NS by almost all relevant studies.
Table 2 Antibiotic Resistance Of Group B Streptococci (GBS)
And Staphylococcus aureus
GBS (n/N/%) S. aureus
(n/N/%)
Penicillin 0 80 0.0 37 42 88.1
Ampicillin 0 70 0.0 – – –
Erythromycin 61 78 70.9 14 42 33.3
Tetracycline 76 81 88.4 5 42 11.9
Clindamycin 55 81 64.0 14 42 33.3
Nitrofurantoin 0 69 0.0 1 42 2.4
Ciprofloxacin 10 71 11.6 0 42 0.0
Moxifloxacin 8 68 9.3 0 42 0.0
Levofloxacin 9 73 10.5 0 42 0.0
Vancomycin 0 80 0.0 0 42 0.0
Tigecycline 0 62 0.0 0 42 0.0
Quinapril/duphuddin 0 71 0.0 0 42 0.0
Linezolid 1 76 1.2 0 42 0.0
Oxacillin – – – 8 42 19.0
Cefazolin – – – 5 22 22.7
Cefaclor – – – 5 22 22.7
Cefuroxime – – – 5 22 22.7
Cefoperazone – – – 5 22 22.7
Ceftriaxone – – – 5 22 22.7
Ceftazidime – – – 5 22 22.7
Rifampicin – – – 0 42 0.0
Trimethoprim/sulfamethoxazole – – – 2 42 4.8
Gentamycin – – – 0 42 0.0
Notes: n, number of resistant isolates; N, number of tested.
Table 3 Antibiotic Resistance Of Escherichia coli And Klebsiella
Pneumoniae
E. coli (n/N/%) K. pneumoniae (n/N/%)
Ampicillin 106 134 79.1 126 127 99.2
Ampicillin/sulbactam 37 131 27.6 70 122 55.1
Piperacillin/
tazobactam
2 130 1.5 7 124 5.5
Cefazolin 57 128 42.5 82 121 64.6
Ceftazidime 15 134 11.2 41 126 32.3
Ceftriaxone 56 134 41.8 75 127 59.1
Cefepime 6 130 4.5 17 126 13.4
Cefotetan 3 131 2.2 8 122 6.3
Imipenem 1 134 0.7 8 127 6.3
Ertapenem 5 134 3.7 8 120 6.3
Gentamycin 42 134 31.3 26 127 20.5
Amikacin 1 134 0.7 2 127 1.6
Tobramycin 4 131 3.0 5 122 3.9
Furadantin 14 131 10.4 24 122 18.9
Aztreonam 26 131 19.4 45 123 35.4
Ciprofloxacin 44 134 32.8 9 127 7.1
Levofloxacin 29 131 21.6 13 123 10.2
Trimethoprim/
sulfamethoxazole
68 131 50.7 46 122 36.2
Notes: n, number of resistant isolates; N, number tested.
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Figure 3 Incidence rate (per 1000 live births) of Klebsiella pneumoniae, Escherichia coli, Group B Streptococcus (GBS), and Staphylococcus aureus infections in (A) early-onset
sepsis (EOS) and (B) late-onset sepsis (LOS).
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In a comparison with other pathogens, this study was the
first in which GBS was identified as the main bacterial
pathogen associated with early-onset NS in China, which
has received attention for several decades in developed
countries.4,6 Moreover, K. pneumoniae has been frequently
isolated from infants with NS from Asian areas, including
China.12,13 In this study, K. pneumoniae was primarily
responsible for late-onset infection, especially in preterm
infants with low birth weight, in contrast to the increased
rates of E. coli infection among preterm infants reported in
the USA.16 However, why the percentage of K. pneumoniae
in the preterm infants, including those with VLBW and
PLBW, was lower than that in the term infants, which is
a different result from that of other studies,12,13 is currently
unknown. This relation needs to be analyzed in conjunction
with maternal information.
A strength of this study was that the study hospital is
the largest maternity and children’s hospital in South
China and is one of the few medical institutions that
provide continuous service for delivery and pediatric
health care in mainland China. Therefore, the total number
of live births during the study period could be used as the
denominator to learn more precisely about the burden of
NS. Of the 91,215 LBs from 2012 to 2016 in the
GWCMC, the incidence of EOS (0.78 per 1000 LBs)
was comparable to the incidence of 0.7 in the UK but
a little lower than that of 0.98 reported in the USA in
2011, based on culture-proven results.10,16 Of the patho-
gens, K. pneumoniae had the highest incidence of 0.80 per
1000 LBs and was particularly associated with late-onset
infection. Although the incidence was lower, GBS
(0.30 per 1000 LBs) and E. coli (0.11 per 1000 LBs)
were more commonly recorded in EOS, which is a result
similar to that for these two pathogens in the USA.2 The
risk of death (16.2%) was significantly higher for infants
with sepsis associated with E. coli infection than with
K. pneumoniae (8.8%) or GBS (4.9%) infection. Owing
to the incidence and associated fatalities, the important
pathogens to combat and prevent NS in China are
K. pneumoniae and E. coli. The epidemiological findings
strongly demonstrated again the predominance of E. coli
in NS in China and identified GBS and K. pneumoniae as
the most common causative pathogens for EOS and LOS,
respectively. The results hint that it is possible to decrease
the occurrence of EOS to some extent by implementing
preventive measures, according to the successful experi-
ence with GBS in developed countries.6,17
GBS has emerged as amajor pathogen responsible for NS
and meningitis in developed countries since the 1970s.5
Prevention strategies based on intrapartum antibiotic prophy-
laxis in at-risk women resulted in a significant reduction in
early-onset GBS disease.6 By contrast, the relevant data in
developing countries, including China, are scarce, although
according to limited data, GBS disease in some regions of
China is low.18,19 However, recently, GBS cases have been
reported more often, and a nationwide study is underway.20
Nevertheless, the clinical profile of neonatal GBS sepsis is
largely unexplored in China, similar to other eastern areas
including Hong Kong, Malaysia, Thailand, and India.12,20–22
The percentage (13.2%) of GBS associated with NS in this
study is very similar to the result (14.2%) from another
hospital in South China.13 In two other hospitals in South
China, GBS was the predominant pathogen associated with
NS at 5.2–31.3%, which were higher values than those in
middle China during the same period.7,9,23 Moreover, GBS
(46.5%) was recently reported as the leading organism, fol-
lowed by E. coli (23.3%) and S. aureus (7.0%), in infants <3
months old in a multicenter study on Chinese children diag-
nosed with bacterial meningitis between 28 days and 6 years
of age, excluding neonates.24 GBS was the most common
pathogen in both early-onset and late-onset bacterial menin-
gitis. GBS was also the most common pathogen in term
infants in a multicenter retrospective epidemiological study
from 2011 to 2016.25 These findings indicate that geographi-
cal disparity might exist in the spectra of pathogens causing
NS in China. Therefore, the status of neonatal GBS invasive
infection in China needs to be surveyed, and preventive
measures should be taken.
Sepsis ranks as the third most common cause of neona-
tal deaths in China, and Chinese clinicians are generally
more active in the management of neonates with suspected
infections.23 Ampicillin/piperacillin and third-generation
cephalosporin are the choices for the first-line empirical
antibiotics to treat NS in China, whereas ampicillin com-
bined with gentamicin is used in developed areas.21
K. pneumoniae and E. coli received much attention because
of their high rates of multidrug resistance.25 In this study,
E. coli had the same resistance to antibiotics as that found in
other reports from China and in children of different ages.24
However, the high incidence rate of extended-spectrum
β-lactamase producers and the high resistance to ampicillin
and the third-generation cephalosporins continue to suggest
that serious concern is warranted. Regardless of the high
resistance reported consistently to erythromycin or clinda-
mycin, penicillin or ampicillin is effective against GBS in
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China.5,21,26 In general, empirical therapy should be guided
by the antimicrobial resistance patterns of bacterial isolates
commonly detected.
Several limitations occurred in this study. Because the
positive rates of CSF or blood cultures can decrease signifi-
cantly if antibiotics are used more than 24 h before sample
collection, some infants that had NS but were culture-negative
for infection would not have been identified. Although the
study hospital is the largest children’s medical organization in
the local area, there remains a small portion of the infants born
inside that will be admitted to their nearest hospital in the case
of emergency. Both of the above-mentioned scenarios would
underestimate the incidence of NS. Additionally, a single sam-
ple with CoNSwas excluded from analysis in the study, which
might have led to bias. Last, maternal histories were not
collected and analyzed, even though they would provide
important information about exposure to infectious disease
and bacterial colonization, natural and acquired immunity,
and obstetric risk factors.
In summary, K. pneumoniae, E. coli, GBS, and S. aureus
were the predominant pathogens in culture-provenNS inSouth
China. This study was the first to use epidemiological data of
a population in China to reveal that K. pneumoniae was the
most frequent pathogen.Klebsiella pneumoniaewas primarily
associated with late-onset sepsis in preterms, whereas GBS
predominated the pathogens associatedwith early-onset sepsis.
Escherichia coli was common in both EOS and LOS with the
highest mortality. As optimal prevention and treatment strate-
gies are considered, continued surveillance tomonitor changes
in pathogens, disease severity, and outcome is important. The
results of this study will contribute to the management of
neonatal sepsis by focusing on the pathogens that may have
been overlooked in the past.
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